Unknown Manufacturer
NCX 950, beta2-adrenoceptor agonists is widely used in the treatment of pulmonary diseases.
NCX 950, beta2-adrenoceptor agonists is widely used in the treatment of pulmonary diseases.
NCX-950 elicits potent relaxant and anti-inflammatory activities compared with salbutamol, and these effects may be mainly due to the activation of the beta2-adrenoceptor rather than the cGMP pathway.
Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD).
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
